Arca
Skip to content
Tools
Tools

Medcura, Inc.

7 private offerings reported to the SEC on Form D since 2016, $60.2M sold in all. Biotech, Maryland.

  • Form D offerings: 7
  • Reported sold: $60.2M
  • Newest: Jul 25, 2025
  • FDA records: Company page

Every Form D offering

Newest first; an amended notice updates the amount sold. Each filing opens on EDGAR.
Jul 25, 2025—$28.5M$38.3MMedcura, Inc.Biotech · MarylandNot amended0000929638-25-002712
Aug 16, 2022—$22.5M$22.8MMedcura, Inc.Biotech · MarylandJul 24, 20240001567619-22-016358
Nov 2, 2021—$3.5M$5.8MMedcura, Inc.Biotech · MarylandNot amended0001567619-21-019159
Sep 28, 2020—$3.0M$5.0MMedcura, Inc.Biotech · MarylandNot amended0001567619-20-017138
Jul 2, 2018—$1.6M$2.5Mgel-e, Inc.Biotech · MarylandNot amended0001672180-18-000001
Sep 20, 2016—$1.1M$3.1Mgel-e, Inc.Biotech · MarylandNov 10, 20160001672180-16-000003
Apr 14, 2016—$11$200Remedium Technologies, INC.Biotech · MarylandNot amended0001671724-16-000001

SEC Profile

From the company's EDGAR record
Business address
Riverdale, MD
Incorporated in
Delaware
Former names
gel-e, Inc.; Remedium Technologies, INC.
All SEC filings
CIK 1672180 on EDGAR

A Form D reports the amount offered and sold so far in a private offering, not who invested or at what valuation. Shares issued in a merger are left out. The profile is read from EDGAR daily. SEC Form D data sets and EDGAR

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.